Downloads provided by UsageCounts
Bacterial secondary metabolites have been studied for decades for their usefulness as drugs, such as antibiotics. However, the identification of new structures has been decelerating, while multi-resistant pathogens continue to emerge. It is unclear how much chemical diversity exists in Nature and whether discovery efforts should be focused on established antibiotic producers or rather on understudied taxa. Here, we surveyed around 170,000 bacterial genomes and several thousand of Metagenome Assembled Genomes (MAGs). Our results indicate that only 3% of the genomic potential for natural products has been experimentally discovered. Our analysis connects the emergence of most biosynthetic diversity in evolutionary history close to the taxonomic rank of genus, identifies Streptomyces as by far the most biosynthetically diverse, followed by producers from genera such as Amycolatopsis, Kutzneria and Micromonospora, and highlights multiple promising high-producing taxa that have thus far been less investigated, such as Weeksellaceae (Bacteroidota), Myxococcaceae (Myxococcota), Pleurocapsa, Nostocaceae (Cyanobacteria).
Supplementary tables have been updated after inclusion of an additional dataset to the analysis.
| citations The total number of citations received by all articles of the researcher of interest. | 3 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
| views | 219 | |
| downloads | 71 |

Views provided by UsageCounts
Downloads provided by UsageCounts